>
Fuso Pharmaceutical Industries logo

4538 - Fuso Pharmaceutical Industries Share Price

¥2303 22.0  1.0%

Last Trade - 7:00am

Sector
Healthcare
Size
Small Cap
Market Cap £129.1m
Enterprise Value £166.3m
Revenue £317.8m
Position in Universe 1905th / 3896
Bullish
Bearish
Unlock 4538 Revenue
Momentum
Relative Strength (%)
1m -5.87%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -26.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
45,752 46,782 45,900 46,074 46,901 49,251 +1.5%
-87.1 +1,046 +15.6 +54.8 -20.5 +114.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2021, FusoPharmaceutical Industries Ltd revenues increased 5% toY49.25B. Net income applicable to common stockholdersincreased from Y707M to Y1.61B. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income benefitedfrom SP Gain on sale of fixed assets increase from Y38M toY91M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 4538
Graphical History

Revenue

4538 Revenue Unlock 4538 Revenue

Net Income

4538 Net Income Unlock 4538 Revenue

Normalised EPS

4538 Normalised EPS Unlock 4538 Revenue

PE Ratio Range

4538 PE Ratio Range Unlock 4538 Revenue

Dividend Yield Range

4538 Dividend Yield Range Unlock 4538 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4538 EPS Forecasts Unlock 4538 Revenue
Profile Summary

Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.

Directors
Last Annual March 31st, 2021
Last Interim March 31st, 2021
Incorporated March 25, 1937
Public Since December 22, 1989
No. of Shareholders: n/a
No. of Employees: 1,352
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Tokyo Stock Exchange
Shares in Issue 8,772,749
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4538 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4538
Upcoming Events for 4538
Friday 25th June, 2021 Estimate
Fuso Pharmaceutical Industries Ltd Annual Shareholders Meeting
Tuesday 10th August, 2021 Estimate
Q1 2022 Fuso Pharmaceutical Industries Ltd Earnings Release
Wednesday 29th September, 2021
Dividend For 4538.T - 30.0000 JPY
Monday 8th November, 2021 Estimate
Q2 2022 Fuso Pharmaceutical Industries Ltd Earnings Release
Frequently Asked Questions for Fuso Pharmaceutical Industries
What is the Fuso Pharmaceutical Industries share price?

As of 7:00am, shares in Fuso Pharmaceutical Industries are trading at ¥2303, giving the company a market capitalisation of £129.1m. This share price information is delayed by 15 minutes.

How has the Fuso Pharmaceutical Industries share price performed this year?

Shares in Fuso Pharmaceutical Industries are currently trading at ¥2303 and the price has moved by -11.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fuso Pharmaceutical Industries price has moved by -31.68% over the past year.

What are the analyst and broker recommendations for Fuso Pharmaceutical Industries?

Of the analysts with advisory recommendations for Fuso Pharmaceutical Industries, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Fuso Pharmaceutical Industries is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Fuso Pharmaceutical Industries next release its financial results?

Fuso Pharmaceutical Industries is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Fuso Pharmaceutical Industries dividend yield?

The Fuso Pharmaceutical Industries dividend yield is 2.63% based on the trailing twelve month period.

Does Fuso Pharmaceutical Industries pay a dividend?

Last year, Fuso Pharmaceutical Industries paid a total dividend of 60, and it currently has a trailing dividend yield of 2.63%. Looking ahead, shares in Fuso Pharmaceutical Industries are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-06-30.

When does Fuso Pharmaceutical Industries next pay dividends?

Fuso Pharmaceutical Industries are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-06-30. The historic dividend yield on Fuso Pharmaceutical Industries shares is currently 2.63%.

How do I buy Fuso Pharmaceutical Industries shares?

To buy shares in Fuso Pharmaceutical Industries you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Fuso Pharmaceutical Industries?

Shares in Fuso Pharmaceutical Industries are currently trading at ¥2303, giving the company a market capitalisation of £129.1m.

Where are Fuso Pharmaceutical Industries shares listed? Where are Fuso Pharmaceutical Industries shares listed?

Here are the trading details for Fuso Pharmaceutical Industries:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4538
What kind of share is Fuso Pharmaceutical Industries?

Based on an overall assessment of its quality, value and momentum, Fuso Pharmaceutical Industries is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Fuso Pharmaceutical Industries share price forecast 2021?

We were not able to load any forecast data for Fuso Pharmaceutical Industries.

How can I tell whether the Fuso Pharmaceutical Industries share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fuso Pharmaceutical Industries. Over the past six months, the relative strength of its shares against the market has been -28.13%. At the current price of ¥2303, shares in Fuso Pharmaceutical Industries are trading at -13.64% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Fuso Pharmaceutical Industries PE Ratio?

The Fuso Pharmaceutical Industries PE ratio based on its reported earnings over the past 12 months is 12.89. The shares are currently trading at ¥2303.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Fuso Pharmaceutical Industries?

Fuso Pharmaceutical Industries's management team is headed by:

Mikio Toda - PRE
Junichi Miyanagi - DSL
Takahiko Chigita - OTH
Shokichi Nishimura - OTH
Yukinobu Matsui - CEX
Junichi Oka - OTH
Yoshikazu Ishii - CEX
Shuto Naka - OTH
Masanori Ito - OTH
Hideki Ohtani - DSL
Who are the major shareholders of Fuso Pharmaceutical Industries?

Here are the top five shareholders of Fuso Pharmaceutical Industries based on the size of their shareholding:

Budoh Kyowakai Association Corporation
Percentage owned: 6.24% (590k shares)
Shikishima Shinko Company Corporation
Percentage owned: 4.78% (452k shares)
Sumitomo Mitsui Banking Corp Bank and Trust
Percentage owned: 4.54% (429k shares)
Sumitomo Mitsui Trust Bank, Limited Bank and Trust
Percentage owned: 4% (378k shares)
MUFG Bank, Ltd. Bank and Trust
Percentage owned: 3.65% (345k shares)
Similar to 4538
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.